The funding will primarily be used for commercialisation of Zeus V1 across India, Europe
Chiratae Ventures today announced their seed investment in Aether Biomedical, a medical robotics company focussed on developing rehabilitation devices based on biosignal processing as a part of their DeepTech Innovators Programme. Other investors that participated in the round include Joyance partners & Sunfish partners. The funding will primarily be used for the commercialisation of Zeus V1 across India and Europe. The company also aims to continue its R&D efforts by building the next generation of the bionic limb and building accessory products like prosthetic wrists and prosthetic elbows.
This DeepTech Innovators Programme by Chiratae Ventures is the sixth edition consolidating all the previous programmes for the seed and early-stage start-ups with a focus on solving real, major problems through deep-technology across sectors. This cohort saw participation from more than 250+ companies across horizontal tech, mobility, robotics, energy, aerospace, biotech, life sciences, etc. This initiative is in-line with Chiratae’s continued effort to back deep technology solutions and boost innovative thinking coming out of India.
Aether’s first product Zeus, a multi-action bionic limb, is a low-cost high efficacy product aimed to create data-driven rehabilitation accessible and more robust. Their state-of-the-art product offers one of the highest grip forces in the market and is priced at a much affordable rate to bring a larger set of amputees under their purview. They have been able to achieve this by employing some of the latest advancements in biosignal processing, machine learning, and additive manufacturing which have the potential to further expand the scope of their solutions in the broader sphere of data-driven rehabilitation. The company led by Dhruv Agrawal and Faith Jiwakhan built this product after studying core aspects of robotics, mechatronics and continue to do so and bring the best of medical science and robotics together in this product.
Speaking on the announcement, Sudhir Sethi, Founder & Managing Director, Chiratae Ventures, said “We see Deep-tech playing a pivotal role in shaping scalable solutions across verticals. As technology evolves so does the benchmark for innovation, Aether and its team is a great example of that. Dhruv and Faith share our excitement on bringing to life new-age tech-led solutions positively impacting millions of people around the world and we’re excited to partner with them along with Joyance Partners & Sunfish Partners.
Commenting on the announcement, Dhruv Agrawal, Founder and CEO, Aether Biomedical, said “As an early-stage start-up we’re thrilled by the faith and excitement shown to us by incredible partners such as Chiratae, Joyance and Sunfish. As a company, we’re deeply committed to pushing the boundaries to create solutions that enable fulfilling lives for millions of people across the globe. Building at the intersection of robotics, mechatronics, research, insights and innovation we hope our solutions help 10m+ amputees globally live better lives and re-invent medical tech.”